Polymyxin-induced neuromuscular weakness: a case report

Front Neurol. 2024 Mar 27:15:1342419. doi: 10.3389/fneur.2024.1342419. eCollection 2024.

Abstract

Polymyxin-induced neuromuscular blockade is a rare but potentially fatal condition, with majority of cases that were reported between 1962 and 1973. We describe a patient who developed hypercapnic respiratory failure after initiation of polymyxin for multi-drug resistant Escherichia Coli bacteremia, due to polymyxin-induced neuromuscular dysfunction. After cessation of polymyxin, he regained full strength, had complete resolution of ptosis, and was successfully extubated. In light of the renewed use of polymyxin in this era of antimicrobial-resistance, this case aims to raise awareness about this rare but life-threatening condition, which is easily reversible with early recognition and prompt discontinuation of the drug.

Keywords: multi-drug resistance; neuromuscular blockade; neurotoxicity; polymyxin; renal impairment; respiratory failure.

Publication types

  • Case Reports

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.